mobilee’ What is Mobilee®? Mobilee® is a patented natural ingredient with a high concentration of hyaluronic acid, Mobilee® also contains other natural components [collagen and polysaccharides} that act in synergy to enhance its effects. Effects of Mobilee® Due to the synergy of its components, Mobilee® has demonstrated: 10 fold increase of the endogenous synthesis of hyaluronic acid in joints. Reduction of inflammation by lowering Prostaglandin E2. Reduction of clinical synovial effusion and joint discomfort. Increase of muscle strength. Mobility and healthy ageing © Consumers in the 40-65 years old range are in products that will help them with their desire to maintain an active lifestyle, and keep healthy through exercise and nutrition. © Joint disconfort is a very prevalent condition that disables to keep an active way of life. © 43% of people between 45-65 years old suffer from joint discomfort. "! (inom Ropat ne Ota tr fr 2 (at art at Shes ath Uta 1 tt M212 Why Mobilee®? Launch anew product for a growing target, with 2 unique food ingredient: © Effective: 4 double blind placebo controlled randomized clinical trials. © Easy to formulate: low dose (80 mg/day). © Solid Regulatory framework: Novel Food and GRAS approved. © Developed by Bioiberica, the expert in Joint Health. @o BIOIBERICA| Scientific evidence Stimulation of the endogenous synthesis of hyaluronic acid [increase of 10-fold endogenous HA secretion) I mMobilee* (200)9/m Placebo Reduction of joint discomfort © Placebo Mot be seh 01- Antara mobilee’ ;:. meyes Regulatory status Reduction of inflammation by lowering levels of Prostaglandin E2 [PGE2} : ™ ~~ IL-1hB + Mobitee (500ug/mt) None ith mgfro Increase of muscular strenght Motilee® promates joint health and supports mobility 40-80 mg/day Novel food & self-affirmed GRAS approved About Bioiberica Leader in Joint Care Its activities include research, development, production and marketing of products forthe pharmaceutical, food supplements and functional food markets, Vertically intear BIOIBERICA pla client's disposal to achieve a Since 1978, BIOIBERICAhas steadily consolidated its position as an international leader in joint care from the active ingredient to the finished product al fits medical, scientific and marketing knowledge at the 39 and innovative line of joint care product.